Expression of CD26 does not correlate with the replication of macrophage-tropic strains of HIV-1 in T-cell lines

Virology

Volumn 224, Issue 1, 1996, Pages 276-280

  Watkins, Brynmor A ^a   Crowley, Richard W ^a   Davis, Alberta E ^a   Louie, Audrey T ^a,b   Reitz Jr , Marvin S ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ADSORPTION; VIRUS REPLICATION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030273052     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0529     Document Type: Article

References (37)

1. Bergeron, L., Sullivan, N., and Sodroski, J. (1992). Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. J. Virol. 66, 2389-2397.
2. Blazquez, M. V., Madueno, J. A., Gonzalez, R., Jurado, R., Bachovchin, W. W., Pena, J., and Munoz, E. (1992). Selective decrease of CD26 expression in T cells from HIV-1 -infected individuals. J. Immunol. 149, 3093-3097.
3. + cells. Science 262, 2045-2050.
4. Carrillo, A., Trowbridge, D. B., Westervelt, P., and Ratner, L. (1993). Identification of HIV-1 determinants for T lymphoid cell line infection. Virology 197, 817-824.
5. Chesebro, B., Nishio, J., Perryman, S., Cann, A., O'Brien, W., Chen, I.S.Y., and Wherly, K. (1991). Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells and macrophages. J. Virol. 65, 5782-5789.
6. Chesebro, B., Wehrly, K., Nishio, J., and Perryman, S. (1992). Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J. Virol. 66, 6547-6554.
7. Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., and Popovic, M. (1986a). The role of mononuclear phagocytes in HTLV-III.LAV infection. Science 233, 215-219.
8. Gartner, S., Markovits, P., Markovitz, D. M., Betts, R. F., and Popovic, M. (1986b). Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 256, 2365-2371.
9. Gu, R., Westervelt, P., and Ratner, L. (1993). Role of HIV-1 envelope V3 loop cleavage in cell tropism. AIDS Res. Hum. Retroviruses 9, 1007-1015.
10. Harouse, J. M., Bhat, S., Spitalnik, S. L., Laughlin, M., Stefano, K., Silberberg, D. H., and Gonzalez-Scarano, F. (1991). Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253, 320-323.
11. Harrowe, G., and Cheng-Mayer, C. (1995). Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology 210, 490-494.
12. Henkel, T., Westervelt, P., and Ratner, L. (1995). HIV-1 V3 envelope sequences required for macrophage infection. AIDS 9, 399-401.
13. Hwang, S., Boyle, T., Lyerly, H., and Cullen, B. (1991). Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253, 71-74.
14. Kawaoka, Y., and Webster, R. G. (1988). Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc. Natl. Acad. Sci. USA 85, 324-328.
15. Klenk, H. D., Rott, R., Orlich, M., and Blodorn, J. (1975). Activation of influenza A viruses by trypsin treatment. Virology 68, 426-439.
16. Lazaro, I., Naniche, D., Signoret, N., Bernard, A-M., Marguet, D., Klatzmann, D., Dragic, T., Alizon, M., and Sattentau, Q. (1994). Factors involved in the entry of the human immunodeficiency virus type 1 into permissive cells: Lack of evidence of a role for CD26. J. Virol. 68, 6535-6546.
17. Lusso, P., Cocchi, F., Balotta, C., Markham, P. D., Louie, A., Farci, P., Pal, R., Gallo, R. C., and Reitz, M. S., Jr. (1995). Growth of macrophagetropic and primary human immuno-deficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): Failure to down regulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69, 3712-3720.
18. Morimoto, C., Lord, C. I., Zhang, C., Duke-Cohan, J. S., Letvin, N. L., and Schlossman, S. F. (1994). Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc. Natl. Acad. Sci. USA 91, 9960-9964.
19. O'Brien, W. A., Koyanagi, Y., Namazie, A., Zhao, J. Q., Diagne, A., Idler, K., Zack, J. A., and Chen, I. S. Y. (1990). HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 348, 69-73.
20. Okada, T., Patterson, B. K., Otto, P. A., and Gurney, M. E. (1994). HIV type 1 infection of CD4+ T cells depends critically on the basic amino acid residues in the V3 domain of envelope glycoprotein 120. AIDS Res. Hum. Retroviruses 10, 803-811.
21. Oravecz, T., Roderiquez, G., Koffi, J., Wang, J., Ditto, M., Bou-Habib, D. C., Lusso, P., and Norcross, M. (1995). CD26 expression correlates with entry, replication and cyto-pathicity of monocytotropic HIV-1 strains in a T-cell line. Nature Med. 1, 919-926.
22. Parmantier, E., Monge, M., Yagello, M., Cabon, F., Demerens, C., Gluckman, J. C., and Zalc, B. (1995). HIV-1 envelope glycoprotein gp120 does not bind to galactosyl-ceramide-expressing rat oligodendrocytes. Virology 206, 1084-1089.
23. Raff, M. C. (1989). Glial cell diversification in the rat optic nerve. Science 243, 1450-1455.
24. Schuitemaker, H., Kootstra, N. A., de Goede, R. E. Y., de Wolf, F., Miedema, F., and Tersmette, M. (1991). Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium inducing ability in primary T-cell culture. J. Virol. 65, 356-363.
25. Shoida, T., Levy, J. A., and Cheng-Mayer, C. (1991). Macrophage and T cell-line tropisms are determined by specific regions of the envelope gp120 gene. Nature 349, 167-169.
26. Shioda, T., Levy, J. A., and Cheng-Mayer, C. (1992). Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89, 9434-9438.
27. Stamatatos, L., and Cheng-Mayer, C. (1995). Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. J. Virol. 69, 6191-6198.
28. Stamatatos, L., and Levy, J. A. (1994). CD26 is not involved in infection of peripheral blood mononuclear cells by HIV-1. AIDS 8, 1727-1743.
29. Tanaka, T., Camarini, D., Seed, B., Torimoto, Y., Dang, N. H., Kameoka, J., Dahlberg, H. N., Schlossman, S. F., and Morimoto, C. (1992). Cloning and functional expression of the T cell antigen CD26. J. Immunol. 149, 481-486.
30. Watkins, B. A., Dorn, H. H., Kelly, W. B., Armstrong, R. C., Potts, B. J., Micheals, F., Kufta, C. V., and Dubois-Dalcq, M. (1990). Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 249, 549-553.
31. Werner, A., Mattern, T., Ulmer, A. J., Flad, H. D., Kurth, R., and Baier, M. (1994). CD26 is not required for the infection of the lymphoma cell line C8166 with HIV-1. AIDSS, 1348-1349.
32. West, W. H. L., and Stott, E. J. (1994). Cell surface expression of CD26 does not correlate with susceptibility to immunodeficiency viruses. AIDS 8, 1349-1350.
33. Westervelt, P., Gendelman, H. E., and Ratner, L. (1991). Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl. Acad. Sci. USA 88, 3097-3101.
34. Westervelt, P., Trowbridge, D. B., Epstein, L. G., Blumberg, B. M., Li, Y., Hahn, B. H., Shaw, G. M., Price, R. W., and Ratner, L. (1992). Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 66, 2577-2582.
35. Yahi, N., Sabatier, J. M., Baghdiguian, S., Gonzalez-Scarano, F., and Fantini, J. (1995). Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosyl-ceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line. J. Virol. 69, 320-325.
36. Yewdell, J. W., Gerhard, W., and Bachi, T. (1983). Monoclonal antihemagglutinin antibodies detect irreversible antigenic alterations that coincide with the acid activation of influenza virus A/PR/834-mediated hemolysis. J. Virol. 48, 239-248.
37. Zhirnov, O. P., Ovcharenko, A. V., and Bukrinskaya, A. G. (1992). Proteolytic activation of influenza WSN virus in cultured cells is performed by homologous plasma enzymes. J. Gen. Virol. 63, 469-474.